These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 17846102)

  • 61. Citalopram for verbal agitation in patients with dementia.
    Kim KY; Bader GM; Jones E
    J Geriatr Psychiatry Neurol; 2000; 13(2):53-5. PubMed ID: 10912724
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Psychopharmacological treatment of behavioral and psychological symptoms in dementia].
    Lolk A; Gulmann NC
    Ugeskr Laeger; 2006 Oct; 168(40):3429-32. PubMed ID: 17032610
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.
    Feldman PD; Kaiser CJ; Kennedy JS; Sutton VK; Tran PV; Tollefson GD; Zhang F; Breier A
    J Clin Psychiatry; 2003 Sep; 64(9):998-1004. PubMed ID: 14628974
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease.
    Weintraub D; Drye LT; Porsteinsson AP; Rosenberg PB; Pollock BG; Devanand DP; Frangakis C; Ismail Z; Marano C; Meinert CL; Mintzer JE; Munro CA; Pelton G; Rabins PV; Schneider LS; Shade DM; Yesavage J; Lyketsos CG;
    Am J Geriatr Psychiatry; 2015 Nov; 23(11):1127-33. PubMed ID: 26238225
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation.
    Chan HY; Lin AS; Chen KP; Cheng JS; Chen YY; Tsai CJ
    J Clin Psychopharmacol; 2013 Dec; 33(6):747-52. PubMed ID: 24100785
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Open-label, observational study of the effects of risperidone on the behavioral and psychological symptoms of dementia and caregiver stress in the community setting.
    Arriola E; Ignacio Diago J; Antonio Burón J; Gallego R;
    Am J Geriatr Pharmacother; 2005 Mar; 3(1):8-16. PubMed ID: 16089242
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
    Conley RR; Mahmoud R
    Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
    J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia.
    Viscogliosi G; Chiriac IM; Ettorre E
    J Am Med Dir Assoc; 2017 Sep; 18(9):799-802. PubMed ID: 28739492
    [TBL] [Abstract][Full Text] [Related]  

  • 72. R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.
    Ho T; Pollock BG; Mulsant BH; Schantz O; Devanand DP; Mintzer JE; Porsteinsson AP; Schneider LS; Weintraub D; Yesavage J; Drye LT; Munro CA; Shade DM; Lyketsos C; Bies R
    Br J Clin Pharmacol; 2016 Sep; 82(3):784-92. PubMed ID: 27145364
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [New formulations of olanzapine in the treatment of acute agitation].
    Bartkó G
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):171-8. PubMed ID: 17211052
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rationale and guidelines for the inpatient treatment of acute psychosis.
    Feifel D
    J Clin Psychiatry; 2000; 61 Suppl 14():27-32. PubMed ID: 11154014
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder.
    Janicak PG; Keck PE; Davis JM; Kasckow JW; Tugrul K; Dowd SM; Strong J; Sharma RP; Strakowski SM
    J Clin Psychopharmacol; 2001 Aug; 21(4):360-8. PubMed ID: 11476119
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Duration of risperidone treatment for BPSD.
    Snowdon J; Brodaty H; Ames D; Day S
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
    [No Abstract]   [Full Text] [Related]  

  • 78. A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group.
    Davidson M; Harvey PD; Vervarcke J; Gagiano CA; De Hooge JD; Bray G; Dose M; Barak Y; Haushofer M
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):506-14. PubMed ID: 10861916
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review].
    Zuidema SU; van Iersel MB; Koopmans RT; Verhey FR; Olde Rikkert MG
    Ned Tijdschr Geneeskd; 2006 Jul; 150(28):1565-73. PubMed ID: 16886695
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
    Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.